Vaccines: The new Australian best-practice schedule

Medical Journal of Australia

Volumn 180, Issue 10, 2004, Pages 494-496

  Burgess, Margaret A ^a   McIntyre, Peter B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; POLIOMYELITIS VACCINE; VARICELLA ZOSTER VACCINE;

AUSTRALIA; CHICKENPOX; COST EFFECTIVENESS ANALYSIS; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEPATITIS B; HUMAN; INFLUENZA; MASS IMMUNIZATION; MEASLES; MEDICAL PRACTICE; MENINGOCOCCOSIS; MUMPS; PERTUSSIS; POLIOMYELITIS; RUBELLA; STREPTOCOCCUS INFECTION; TETANUS;

EID: 2542492973     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06050.x     Document Type: Editorial

References (13)

1. McIntyre P, Gidding H, Gilmour R, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Commun Dis Intell 2002; 26 Suppl 1: S1-S111.
2. Torvaldsen S, McIntyre PB. The effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatr Infect Dis J 2003; 22: 956-959.
3. Salmaso S, Mastrantonio P, Tozzi AE, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001; 108: e81.
4. Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004. In press.
5. Gold MS, Noonan S, Osbourn M, et al. Local reactions after the fourth dose of acellular pertussis vaccine in South Australia. Med J Aust 2003; 179: 191-194.
6. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: Updated recommendations of the Advisory Committee on Immunisation Practices. MMWR Rec Rep 2000; 49 (RR-5): 1-22.
7. Australian Technical Advisory Group on Immunisation of the Commonwealth Department of Health and Ageing. Australian Immunisation Handbook. 8th edition. Available at: http://immunise.health.gov.au/handbook.htm (accessed Dec 2003).
8. Tucker AW, Isaacs D, Burgess M. Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia. Aust N Z J Public Health 2001; 25: 411-416.
9. Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia. Vaccine 2000; 18: 407-415.
10. Butler JRG, McIntyre P, MacIntyre CR, et al. The cost-effectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 2004; 22: 1138-1149.
11. Lieu T, Cochi SH, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375-381.
12. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
13. Ehreth J. The value of vaccination: a global perspective. Vaccine 2003; 21: 4104-4117.